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Infiltration of Platelet-Rich Plasma (PRP) may be 
considered as a recent therapeutic option for chronic 
tendinopathies. The aim of this study is to evaluate 
the clinical status and the return to sports activities in 
patients with chronic proximal patellar tendinopa-
thies.
Twenty subjects with chronic proximal patellar ten-
dinopathy benefited from 1 infiltration of PRP cou-
pled with a standardized eccentric rehabilitation. The 
follow-up (up to 1 year) was assessed by means of a 
Visual Anologue Scale (VAS), the International Knee 
Documentation Committee (IKDC) form and the 
 Victorian Institute of Sport Assessment (VISA-P) 
score. Moreover, subjects had to answer an informa-
tion questionnaire concerning their life and sports 
 activities. 
Seventy percents of the patients reported a favour-
able evolution with decrease of pain, and returned to 
sports activities. With time, VAS dropped significant-
ly and both IKDC and VISA-P scores improved also 
significantly.
This study confirms that a local injection of PRP cou-
pled with a program of eccentric rehabilitation for 
treating a chronic jumper’s knee, improves pain 
symptoms and the functionalities of the subjects’ knee 
up to 1 year after injection.
Keywords : platelet-rich plasma ; PRP ; jumper’s knee ; 
patellar tendinopathy ; sport ; apheresis.
INTRODUCTION
Tendinopathy is highly prevalent and is one of 
the most frequently self-reported musculoskeletal 
issues in sportsmen and physical workers (13). 
Jumper’s knee is a frequent chronic overuse syn-
drome of the proximal part of the patellar ten-
don (13). Conservative treatments are not complete-
ly satisfactory and the recurrence of symptoms is 
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common. This is why different experimental treat-
ments are now being developed including Platelet-
Rich  Plasma (PRP) infiltration (9). By releasing dif-
ferent platelet growth factors, PRP may be a new 
therapeutic option for chronic tendinopathies (21). 
Its ease of preparation, relatively low cost, and min-
imal invasiveness are arguments in its favour (21). 
Moreover, PRP has been removed from the doping 
drugs list of the World Anti-Doping Agency since 
2011. Despite the proven efficacy of PRP in tissue 
regeneration in vitro (11), there is currently little tan-
gible clinical evidence for its effectiveness in chron-
ic tendon disorders (9,21). The few studies that have 
been performed appear difficult to compare ; they 
use different PRP preparations with varying quali-
ties (15), various injection methods, and different 
post-infiltration protocols (9,21). Moreover, data on 
long-term results are lacking (9,21).
The objective of this study is to evaluate the 
 clinical status and return to sporting activities in pa-
tients with chronic superior patellar tendinopathies 
1 year after 1 infiltration of PRP and to assess how 
this date evolved since the 3-month follow-up 
 evaluation (10).
MATERIALS AND METHODS
This is a 1-year follow-up of our previous published 
prospective case series (10), which was accepted by the 
Ethic Committee of our institution. We used an experi-
mental protocol according to our first study (10).
Twenty patients (17 men and 3 women, mean age 
28.8 ± 8.2 y.o.) with a chronic proximal patellar tendi-
nopathy (diagnosed clinically and confirmed by ultra-
sounds and/or magnetic resonance imaging) for more 
than 3 months (mean 17.6 months ; from 4 to 62 months) 
were recruited in our Physical Medicine and Sports Trau-
matology Department (after having signed an informed 
 consent form), and met the following inclusion criteria : 
proximal patellar tendinopathy for longer than 3 months, 
and no satisfactory improvement after 3 months of con-
servative management (including eccentric intervention 
and shock wave therapy). No treatment could be applied 
during the last month before infiltration of PRP. The 
sports they practiced were (some subjects practiced more 
than 1 sport) : soccer (n = 8), jogging (n = 4), basketball 
(n = 3), karate (n = 3), volleyball (n = 2), tennis (n = 2), 
judo (n = 2), mountain biking (n = 2) and boxing (n = 1). 
Due to pain, their sports capacities were decreased or im-
possible.
Platelets were collected using an apheresis machine 
(COM.TEC and kit CS5L, Fresenius-Kabi, Bad-Hom-
burg, Germany) (18). This machine offered a reproducible 
PRP from the autologous blood of each patient, with only 
very limited concentration of white and red blood 
cells (18). We decided to collect platelets with a concen-
tration of around 8-9.105 platelets/µL (18). Just before 
 infiltration, 300 µL of CaCl2 were added to the PRP to 
activate the platelets. Six millilitres of PRP were injected 
in the patellar tendon after disinfection without local 
 anaesthetic (7). In case of pain, they could not take any 
anti-inflammatory drugs, but only classical painkillers, 
up to 3 months after the infiltration. After one week of 
relative rest, they started a standardised progressive 
 sub-maximal eccentric program supervised by a physical 
therapist, 3 times a week, 5 sessions of 15 repetitions, for 
6 weeks (14). This eccentric exercise was done using the 
weight of the patient’s body, with the back against the 
wall. The patient would slide slowly his back down the 
wall until his pathologic leg would be bent at 60° before 
pushing on both legs to return to the starting position. 
The angulation and the number of sessions were 
 progressively increased during the reeducation, respec-
tively from 60° to 90° and from 5 to 7 sessions of 15 to 
20 repetitions. Thirty  seconds of rest were allowed 
 between the sessions. The patient benefited also from 
electro-stimulation, stretching of the quadriceps, and 
cryotherapy. Ten minutes of cycloergometer with low 
resistance were also added to the program after 2 post-
infiltrative weeks, and proprioception exercises were 
 introduced after 1 month.
After, six weeks they were authorised to start progres-
sively their sports activities. However, they were encour-
aged to apply ice locally after efforts and to continue 
their eccentric exercises individually following the same 
eccentric and stretching modalities. The mean score of 
compliance with the auto-reeducation was calculated us-
ing a scale from 0 (no compliance) to 10 (maximum com-
pliance).
One year after infiltration, patients were contacted by 
phone by the same examiner who reproduced, as much as 
possible, the same evaluation condition as for the 
3-month follow-up. Estimate of pain intensity quantified 
on a VAS was compared to date before infiltration and 
3 months after infiltration. Similarly, the VISA-P and 
IKDC scores were compared at these 3-time points. 
 Patients were also asked to fill out a standardised 
 questionnaire on the pain severity and the return to sports 
activities :
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– pain during daily, professional and sports activities ;
– the sport they practiced (the same or not as before 
 tendinopathy) ;
– the level of sport they practiced (the same or not as 
before tendinopathy).
Results were expressed as the mean ± standard devia-
tion of the mean (SD) or as percentages. The compari-
sons before infiltration and after 3 months and 1 year 
were made using an ANOVA. Pearson correlation coef-
ficients were used to assess the relationship between 
changes in various outcomes. Changes in the various out-
comes observed after 12 months of follow-up were also 
compared between patients with a 3-month change in 
symptoms below or over the median. The results were 
regarded as significant at the level of 5% (p < 0.05). 
 Statistical analyses were done with the software Statisti-
cal Analysis System, version 9.1 (SAS Institute, Caro, 
NC).
RESULTS
The concentration of the PRP used for the infil-
tration was 884.88 ± 70.82 × 103/µL, with nearly 
no red (< 0.001 × 106/µL) or white cells (< 0.001 × 
103/µL). No significant difference was observed be-
tween platelet concentrations of the PRP injected in 
the whole group of patients.
After 3 months, from the 20 patients, 15 were 
able to return to sport (75%) : 10 to the same sport 
as before infiltration (50%) and 7 to the same level 
of practice (35%) ; 5 (25%) had still a disabling pain 
which prevent them to return to sport. After 1 year, 
14 (70%) reported a favourable evolution with a 
significant decrease or disappearance of pain, 3 
(15%) reported no improvement and 3 (15%) were 
treated surgically. From these 3 patients who bene-
fited from surgery, 1 had still significant pain during 
physical activities and 1 during daily activities.
At one year of follow-up, 12 subjects (60%) re-
ported no pain during daily activities and 11 (55%) 
reported no pain during their job (especially 6 sub-
jects who were physical workers). Fourteen (70%) 
returned to sports activities (soccer (n = 6), jogging 
(n = 4), basketball (n = 2), karate (n = 1), volleyball 
(n = 2), tennis (n = 1), judo (n = 2) and mountain 
biking (n = 1)). From these subjects who returned to 
sport, 64.3% did not feel any pain, and 50% of them 
recovered the same sport level. We have also ob-
served that patients who were younger (less than 
26.5 y.o.) had been more able to return to sport and 
to practice it more often each week (p = 0.003).
VAS scores dropped significantly with time 
(p < 0.0001) : from 6.3 ± 1.9 /10 before infiltration 
to 2.6 ± 2.3 /10 at 3 months and to 1.4 ± 2.1 /10 at 
1 year (Fig. 1a). Moreover, patients who had a 
shorter history of pain (less than 10.5 months) 
seemed to have a better improvement of VAS after 
1 year (p = 0.06).
IKDC scores significantly increased with time 
(p = 0.0007) from 52.7 ± 16.0 before infiltration, to 
61.8 ± 23.3 after 3 months and to 77.0 ± 26.5 after 
1 year (Fig. 1b). VISA-P scores also significantly 
increased with time (p = 0.0087) from 47.9 ± 20.1 
before infiltration, to 65.6 ± 26.4 after 3 months and 
74.2 ± 26.6 after 1 year (Fig. 1c). This corresponds 
to a mean improvement of 74.2% over a year.
Finally, patients who had the greatest reduction 
of pain after 3 months of follow-up also had a better 
improvement after 1 year (p = 0.0004) and they had 
been able to practice sport activities more often 
(p = 0007).
The compliance to auto-reeducation was 
79.2 ± 12.8 % (7.92 ± 1.28/10).
DISCUSSION
Platelet-rich plasma is a relatively innovative 
treatment for chronic tendinopathies (13). During 
degranulation, platelets release various cytokines 
and growth factors which promote angiogenesis, 
tissue remodelling, and tendon healing (21). Even if, 
in vitro and animal experiments have demonstrated 
this stimulation of tendon healing process (11), clini-
cal series are subject to controversy (9). Indeed, var-
ious papers seem to show a benefit to use PRP in 
case of tendinopathy, but one randomized con-
trolled trial on Achilles tendinopathies did not show 
any improvement linked to PRP infiltrations (3). 
Moreover, most of the studies evaluated the PRP 
 effects only at short to medium-term (9). Our study 
followed infiltrated patients up to 1 year, evaluating 
a longer term evolution of the clinical healing pro-
cess of proximal patellar tendinopathy.
The following considerations were not the aim of 
this study but it is essential to remember that these 
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the platelet concentrations and in the amount (if 
any) of red and white blood cells. Leukocytes could 
adversely affect wound healing through the release 
of pro-inflammatory factors responsible for extra-
cellular matrix degradation (3) and lead to a bigger 
early local inflammation (20). In addition, erythro-
cyte lysis releases free radicals that harm tissue 
structures (5). Therefore, a strength of our study is 
that we used an apheresis machine that provided a 
reproducible PRP from one patient to another. The 
platelet concentration was always around 8.5-
9 × 105/µL, and it contained nearly no red or white 
blood cells, corresponding to P3-x-Aα of the PRP 
«PAW» classification system (8). 
Three months after the infiltration of PRP, 75% 
of the patients were able to return to sport. From 
these subjects, 67% were able to practice the same 
sport as before infiltration and 47% to the same lev-
el of practice. Twenty-five percent of patients still 
experienced pain during physical activities and few 
patients stopped practicing sports (10%) (10). 
Among the subjects followed over one year, 15% of 
them underwent surgery after the 3-month follow-
up. Out of these 3 patients, only 1 reported a com-
plete relief of pain ; 1 still felt pain during physical 
activities and 1 during daily living activities. 
Until now, eccentric training has appeared to be 
the treatment of choice for patients suffering from 
patellar tendinopathy (2). It has been demonstrated 
on rat tendons that a mechanical stimulation opti-
mises the healing process of a tendon after PRP 
use (17), and that eccentric training is more efficient 
than concentric training to improve tendon biome-
chanical properties (22). Moreover, this mechanical 
stimulation would have to be initiated as soon as 
possible after PRP infiltration because platelets 
stimulate especially the early phases of tendon heal-
ing process (11). Short after the infiltration of PRP, it 
is thus necessary to apply sub maximal eccentric 
loads, without causing pain, to guide the tendon 
cicatrisation process and to improve its healing (17). 
To observe the effect of PRP associated with an 
eccentric program on chronic superior patellar ten-
dinopathies and rebel to conservative treatments, at 
12 months, the clinical evolution of patients (with-
out surgery) was evaluated using an EVA, as well as 
the IKDC and VISA-P scores. These results were 
elements could condition the efficacy of PRP 
 treatment. Up to now, there is no general agreement 
on the method to prepare PRP and each technique 
provides a very different PRP (15), with variations in 
Fig. 1. — Results for the VAS, IKDC and VISA-P scores be-
fore infiltration, after 3 months and 1 year. * p < 0.05 with time 
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performed on an isokinetic dynamometer, but this 
device is not available at each physiotherapist’s 
practice. Third, our 1-year follow-up could have 
been made in the same way than the 3-months fol-
low-up (10), using functional tests and imagery. 
However, we would have had a lot of drop-out 
 patients. Indeed, some subjects were abroad and 
some returned to work and had less availability for 
our study. Contacting them by phone, allowed us to 
collect data for all the 20 subjects.
CONCLUSIONS
This study confirms that a local injection of PRP 
coupled with a program of eccentric rehabilitation 
to treat a jumper’s knee, improves significantly pain 
symptoms and functionalities of the subjects’ knee 
up to 1 year. Most of the subjects (70%) were able 
to return to sport and half of them recovered the 
same level of sport activities.
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